img

Global RNA-based Biopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global RNA-based Biopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

RNA-based Biopharmaceuticals report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global RNA-based Biopharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Diabetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for RNA-based Biopharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, RNA-based Biopharmaceuticals key manufacturers include Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories, Arrowhead Pharmaceuticals, Benitec Biopharma, Calimmune Inc, Dicerna and Gradalis, etc. Pfizer, Roche, Sanofi-Aventis are top 3 players and held % sales share in total in 2022.
RNA-based Biopharmaceuticals can be divided into Therapeutics and Vaccines, etc. Therapeutics is the mainstream product in the market, accounting for % sales share globally in 2022.
RNA-based Biopharmaceuticals is widely used in various fields, such as Cancer, Diabetes, Tuberculosis and Cardiovascular Diseases, etc. Cancer provides greatest supports to the RNA-based Biopharmaceuticals industry development. In 2022, global % sales of RNA-based Biopharmaceuticals went into Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global RNA-based Biopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Segment by Type
Therapeutics
Vaccines

Segment by Application


Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the RNA-based Biopharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of RNA-based Biopharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the RNA-based Biopharmaceuticals industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of RNA-based Biopharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, RNA-based Biopharmaceuticals introduction, etc. RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of RNA-based Biopharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 RNA-based Biopharmaceuticals Market Overview
1.1 RNA-based Biopharmaceuticals Product Overview
1.2 RNA-based Biopharmaceuticals Market Segment by Type
1.2.1 Therapeutics
1.2.2 Vaccines
1.3 Global RNA-based Biopharmaceuticals Market Size by Type
1.3.1 Global RNA-based Biopharmaceuticals Market Size Overview by Type (2018-2034)
1.3.2 Global RNA-based Biopharmaceuticals Historic Market Size Review by Type (2018-2024)
1.3.3 Global RNA-based Biopharmaceuticals Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific RNA-based Biopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.4 Latin America RNA-based Biopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa RNA-based Biopharmaceuticals Sales Breakdown by Type (2018-2024)
2 Global RNA-based Biopharmaceuticals Market Competition by Company
2.1 Global Top Players by RNA-based Biopharmaceuticals Sales (2018-2024)
2.2 Global Top Players by RNA-based Biopharmaceuticals Revenue (2018-2024)
2.3 Global Top Players by RNA-based Biopharmaceuticals Price (2018-2024)
2.4 Global Top Manufacturers RNA-based Biopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type
2.5 RNA-based Biopharmaceuticals Market Competitive Situation and Trends
2.5.1 RNA-based Biopharmaceuticals Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by RNA-based Biopharmaceuticals Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2022)
2.7 Date of Key Manufacturers Enter into RNA-based Biopharmaceuticals Market
2.8 Key Manufacturers RNA-based Biopharmaceuticals Product Offered
2.9 Mergers & Acquisitions, Expansion
3 RNA-based Biopharmaceuticals Status and Outlook by Region
3.1 Global RNA-based Biopharmaceuticals Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global RNA-based Biopharmaceuticals Historic Market Size by Region
3.2.1 Global RNA-based Biopharmaceuticals Sales in Volume by Region (2018-2024)
3.2.2 Global RNA-based Biopharmaceuticals Sales in Value by Region (2018-2024)
3.2.3 Global RNA-based Biopharmaceuticals Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global RNA-based Biopharmaceuticals Forecasted Market Size by Region
3.3.1 Global RNA-based Biopharmaceuticals Sales in Volume by Region (2024-2034)
3.3.2 Global RNA-based Biopharmaceuticals Sales in Value by Region (2024-2034)
3.3.3 Global RNA-based Biopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global RNA-based Biopharmaceuticals by Application
4.1 RNA-based Biopharmaceuticals Market Segment by Application
4.1.1 Cancer
4.1.2 Diabetes
4.1.3 Tuberculosis
4.1.4 Cardiovascular Diseases
4.1.5 Others
4.2 Global RNA-based Biopharmaceuticals Market Size by Application
4.2.1 Global RNA-based Biopharmaceuticals Market Size Overview by Application (2018-2034)
4.2.2 Global RNA-based Biopharmaceuticals Historic Market Size Review by Application (2018-2024)
4.2.3 Global RNA-based Biopharmaceuticals Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific RNA-based Biopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.4 Latin America RNA-based Biopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa RNA-based Biopharmaceuticals Sales Breakdown by Application (2018-2024)
5 North America RNA-based Biopharmaceuticals by Country
5.1 North America RNA-based Biopharmaceuticals Historic Market Size by Country
5.1.1 North America RNA-based Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America RNA-based Biopharmaceuticals Sales in Volume by Country (2018-2024)
5.1.3 North America RNA-based Biopharmaceuticals Sales in Value by Country (2018-2024)
5.2 North America RNA-based Biopharmaceuticals Forecasted Market Size by Country
5.2.1 North America RNA-based Biopharmaceuticals Sales in Volume by Country (2024-2034)
5.2.2 North America RNA-based Biopharmaceuticals Sales in Value by Country (2024-2034)
6 Europe RNA-based Biopharmaceuticals by Country
6.1 Europe RNA-based Biopharmaceuticals Historic Market Size by Country
6.1.1 Europe RNA-based Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe RNA-based Biopharmaceuticals Sales in Volume by Country (2018-2024)
6.1.3 Europe RNA-based Biopharmaceuticals Sales in Value by Country (2018-2024)
6.2 Europe RNA-based Biopharmaceuticals Forecasted Market Size by Country
6.2.1 Europe RNA-based Biopharmaceuticals Sales in Volume by Country (2024-2034)
6.2.2 Europe RNA-based Biopharmaceuticals Sales in Value by Country (2024-2034)
7 Asia-Pacific RNA-based Biopharmaceuticals by Region
7.1 Asia-Pacific RNA-based Biopharmaceuticals Historic Market Size by Region
7.1.1 Asia-Pacific RNA-based Biopharmaceuticals Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific RNA-based Biopharmaceuticals Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific RNA-based Biopharmaceuticals Sales in Value by Region (2018-2024)
7.2 Asia-Pacific RNA-based Biopharmaceuticals Forecasted Market Size by Region
7.2.1 Asia-Pacific RNA-based Biopharmaceuticals Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific RNA-based Biopharmaceuticals Sales in Value by Region (2024-2034)
8 Latin America RNA-based Biopharmaceuticals by Country
8.1 Latin America RNA-based Biopharmaceuticals Historic Market Size by Country
8.1.1 Latin America RNA-based Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America RNA-based Biopharmaceuticals Sales in Volume by Country (2018-2024)
8.1.3 Latin America RNA-based Biopharmaceuticals Sales in Value by Country (2018-2024)
8.2 Latin America RNA-based Biopharmaceuticals Forecasted Market Size by Country
8.2.1 Latin America RNA-based Biopharmaceuticals Sales in Volume by Country (2024-2034)
8.2.2 Latin America RNA-based Biopharmaceuticals Sales in Value by Country (2024-2034)
9 Middle East and Africa RNA-based Biopharmaceuticals by Country
9.1 Middle East and Africa RNA-based Biopharmaceuticals Historic Market Size by Country
9.1.1 Middle East and Africa RNA-based Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa RNA-based Biopharmaceuticals Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa RNA-based Biopharmaceuticals Sales in Value by Country (2018-2024)
9.2 Middle East and Africa RNA-based Biopharmaceuticals Forecasted Market Size by Country
9.2.1 Middle East and Africa RNA-based Biopharmaceuticals Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa RNA-based Biopharmaceuticals Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
10.1.5 Pfizer Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Roche RNA-based Biopharmaceuticals Products Offered
10.2.5 Roche Recent Development
10.3 Sanofi-Aventis
10.3.1 Sanofi-Aventis Company Information
10.3.2 Sanofi-Aventis Introduction and Business Overview
10.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered
10.3.5 Sanofi-Aventis Recent Development
10.4 Abbott Laboratories
10.4.1 Abbott Laboratories Company Information
10.4.2 Abbott Laboratories Introduction and Business Overview
10.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered
10.4.5 Abbott Laboratories Recent Development
10.5 Arrowhead Pharmaceuticals
10.5.1 Arrowhead Pharmaceuticals Company Information
10.5.2 Arrowhead Pharmaceuticals Introduction and Business Overview
10.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
10.5.5 Arrowhead Pharmaceuticals Recent Development
10.6 Benitec Biopharma
10.6.1 Benitec Biopharma Company Information
10.6.2 Benitec Biopharma Introduction and Business Overview
10.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered
10.6.5 Benitec Biopharma Recent Development
10.7 Calimmune Inc
10.7.1 Calimmune Inc Company Information
10.7.2 Calimmune Inc Introduction and Business Overview
10.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered
10.7.5 Calimmune Inc Recent Development
10.8 Dicerna
10.8.1 Dicerna Company Information
10.8.2 Dicerna Introduction and Business Overview
10.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered
10.8.5 Dicerna Recent Development
10.9 Gradalis
10.9.1 Gradalis Company Information
10.9.2 Gradalis Introduction and Business Overview
10.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered
10.9.5 Gradalis Recent Development
10.10 Quark
10.10.1 Quark Company Information
10.10.2 Quark Introduction and Business Overview
10.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Quark RNA-based Biopharmaceuticals Products Offered
10.10.5 Quark Recent Development
10.11 RXi
10.11.1 RXi Company Information
10.11.2 RXi Introduction and Business Overview
10.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.11.4 RXi RNA-based Biopharmaceuticals Products Offered
10.11.5 RXi Recent Development
10.12 Senesco
10.12.1 Senesco Company Information
10.12.2 Senesco Introduction and Business Overview
10.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Senesco RNA-based Biopharmaceuticals Products Offered
10.12.5 Senesco Recent Development
10.13 Silence Therapeutics
10.13.1 Silence Therapeutics Company Information
10.13.2 Silence Therapeutics Introduction and Business Overview
10.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Products Offered
10.13.5 Silence Therapeutics Recent Development
10.14 Silenseed
10.14.1 Silenseed Company Information
10.14.2 Silenseed Introduction and Business Overview
10.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Silenseed RNA-based Biopharmaceuticals Products Offered
10.14.5 Silenseed Recent Development
10.15 Tekmira
10.15.1 Tekmira Company Information
10.15.2 Tekmira Introduction and Business Overview
10.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Tekmira RNA-based Biopharmaceuticals Products Offered
10.15.5 Tekmira Recent Development
10.16 Alnylam Pharmaceuticals
10.16.1 Alnylam Pharmaceuticals Company Information
10.16.2 Alnylam Pharmaceuticals Introduction and Business Overview
10.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
10.16.5 Alnylam Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 RNA-based Biopharmaceuticals Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 RNA-based Biopharmaceuticals Industrial Chain Analysis
11.4 RNA-based Biopharmaceuticals Market Dynamics
11.4.1 RNA-based Biopharmaceuticals Industry Trends
11.4.2 RNA-based Biopharmaceuticals Market Drivers
11.4.3 RNA-based Biopharmaceuticals Market Challenges
11.4.4 RNA-based Biopharmaceuticals Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 RNA-based Biopharmaceuticals Distributors
12.3 RNA-based Biopharmaceuticals Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Therapeutics
Table 2. Major Company of Vaccines
Table 3. Global RNA-based Biopharmaceuticals Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (K Units)
Table 5. Global RNA-based Biopharmaceuticals Sales Market Share in Volume by Type (2018-2024)
Table 6. Global RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (US& Million)
Table 7. Global RNA-based Biopharmaceuticals Market Share in Value by Type (2018-2024)
Table 8. Global RNA-based Biopharmaceuticals Price by Type (2018-2024) & (USD/Unit)
Table 9. Global RNA-based Biopharmaceuticals Sales by Type (2024-2034) & (K Units)
Table 10. Global RNA-based Biopharmaceuticals Sales Market Share in Volume by Type (2024-2034)
Table 11. Global RNA-based Biopharmaceuticals Sales by Type (2024-2034) & (US$ Million)
Table 12. Global RNA-based Biopharmaceuticals Sales Market Share in Value by Type (2024-2034)
Table 13. Global RNA-based Biopharmaceuticals Price by Type (2024-2034) & (USD/Unit)
Table 14. North America RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (K Units)
Table 15. North America RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe RNA-based Biopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 17. Europe RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific RNA-based Biopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America RNA-based Biopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 21. Latin America RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa RNA-based Biopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa RNA-based Biopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 24. Global RNA-based Biopharmaceuticals Sales by Company (2018-2024) & (K Units)
Table 25. Global RNA-based Biopharmaceuticals Sales Share by Company (2018-2024)
Table 26. Global RNA-based Biopharmaceuticals Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global RNA-based Biopharmaceuticals Revenue Share by Company (2018-2024)
Table 28. Global Market RNA-based Biopharmaceuticals Price by Company (2018-2024) & (USD/Unit)
Table 29. Global RNA-based Biopharmaceuticals Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global RNA-based Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2022)
Table 32. Date of Key Manufacturers Enter into RNA-based Biopharmaceuticals Market
Table 33. Key Manufacturers RNA-based Biopharmaceuticals Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global RNA-based Biopharmaceuticals Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global RNA-based Biopharmaceuticals Sales by Region (2018-2024) & (K Units)
Table 37. Global RNA-based Biopharmaceuticals Sales Market Share in Volume by Region (2018-2024)
Table 38. Global RNA-based Biopharmaceuticals Sales by Region (2018-2024) & (US$ Million)
Table 39. Global RNA-based Biopharmaceuticals Sales Market Share in Value by Region (2018-2024)
Table 40. Global RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global RNA-based Biopharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 42. Global RNA-based Biopharmaceuticals Sales Market Share in Volume by Region (2024-2034)
Table 43. Global RNA-based Biopharmaceuticals Sales by Region (2024-2034) & (US$ Million)
Table 44. Global RNA-based Biopharmaceuticals Sales Market Share in Value by Region (2024-2034)
Table 45. Global RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global RNA-based Biopharmaceuticals Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global RNA-based Biopharmaceuticals Sales by Application (2018-2024) & (K Units)
Table 48. Global RNA-based Biopharmaceuticals Sales Market Share in Volume by Application (2018-2024)
Table 49. Global RNA-based Biopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 50. Global RNA-based Biopharmaceuticals Sales Market Share in Value by Application (2018-2024)
Table 51. Global RNA-based Biopharmaceuticals Price by Application (2018-2024) & (USD/Unit)
Table 52. Global RNA-based Biopharmaceuticals Sales by Application (2024-2034) & (K Units)
Table 53. Global RNA-based Biopharmaceuticals Sales Market Share in Volume by Application (2024-2034)
Table 54. Global RNA-based Biopharmaceuticals Sales by Application (2024-2034) & (US$ Million)
Table 55. Global RNA-based Biopharmaceuticals Sales Market Share in Value by Application (2024-2034)
Table 56. Global RNA-based Biopharmaceuticals Price by Application (2024-2034) & (USD/Unit)
Table 57. North America RNA-based Biopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 58. North America RNA-based Biopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe RNA-based Biopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 60. Europe RNA-based Biopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific RNA-based Biopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific RNA-based Biopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America RNA-based Biopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 64. Latin America RNA-based Biopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa RNA-based Biopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa RNA-based Biopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 67. North America RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 68. North America RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 69. North America RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 70. North America RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 71. North America RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 72. North America RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 73. North America RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 74. North America RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 75. Europe RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 76. Europe RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 79. Europe RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 80. Europe RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific RNA-based Biopharmaceuticals Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific RNA-based Biopharmaceuticals Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific RNA-based Biopharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific RNA-based Biopharmaceuticals Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 92. Latin America RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 96. Latin America RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer RNA-based Biopharmaceuticals Product
Table 111. Pfizer Recent Development
Table 112. Roche Company Information
Table 113. Roche Introduction and Business Overview
Table 114. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Roche RNA-based Biopharmaceuticals Product
Table 116. Roche Recent Development
Table 117. Sanofi-Aventis Company Information
Table 118. Sanofi-Aventis Introduction and Business Overview
Table 119. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi-Aventis RNA-based Biopharmaceuticals Product
Table 121. Sanofi-Aventis Recent Development
Table 122. Abbott Laboratories Company Information
Table 123. Abbott Laboratories Introduction and Business Overview
Table 124. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Abbott Laboratories RNA-based Biopharmaceuticals Product
Table 126. Abbott Laboratories Recent Development
Table 127. Arrowhead Pharmaceuticals Company Information
Table 128. Arrowhead Pharmaceuticals Introduction and Business Overview
Table 129. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 131. Arrowhead Pharmaceuticals Recent Development
Table 132. Benitec Biopharma Company Information
Table 133. Benitec Biopharma Introduction and Business Overview
Table 134. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Benitec Biopharma RNA-based Biopharmaceuticals Product
Table 136. Benitec Biopharma Recent Development
Table 137. Calimmune Inc Company Information
Table 138. Calimmune Inc Introduction and Business Overview
Table 139. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Calimmune Inc RNA-based Biopharmaceuticals Product
Table 141. Calimmune Inc Recent Development
Table 142. Dicerna Company Information
Table 143. Dicerna Introduction and Business Overview
Table 144. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Dicerna RNA-based Biopharmaceuticals Product
Table 146. Dicerna Recent Development
Table 147. Gradalis Company Information
Table 148. Gradalis Introduction and Business Overview
Table 149. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Gradalis RNA-based Biopharmaceuticals Product
Table 151. Gradalis Recent Development
Table 152. Quark Company Information
Table 153. Quark Introduction and Business Overview
Table 154. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Quark RNA-based Biopharmaceuticals Product
Table 156. Quark Recent Development
Table 157. RXi Company Information
Table 158. RXi Introduction and Business Overview
Table 159. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. RXi RNA-based Biopharmaceuticals Product
Table 161. RXi Recent Development
Table 162. Senesco Company Information
Table 163. Senesco Introduction and Business Overview
Table 164. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Senesco RNA-based Biopharmaceuticals Product
Table 166. Senesco Recent Development
Table 167. Silence Therapeutics Company Information
Table 168. Silence Therapeutics Introduction and Business Overview
Table 169. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Silence Therapeutics RNA-based Biopharmaceuticals Product
Table 171. Silence Therapeutics Recent Development
Table 172. Silenseed Company Information
Table 173. Silenseed Introduction and Business Overview
Table 174. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. Silenseed RNA-based Biopharmaceuticals Product
Table 176. Silenseed Recent Development
Table 177. Tekmira Company Information
Table 178. Tekmira Introduction and Business Overview
Table 179. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Tekmira RNA-based Biopharmaceuticals Product
Table 181. Tekmira Recent Development
Table 182. Alnylam Pharmaceuticals Company Information
Table 183. Alnylam Pharmaceuticals Introduction and Business Overview
Table 184. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 186. Alnylam Pharmaceuticals Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. RNA-based Biopharmaceuticals Market Trends
Table 190. RNA-based Biopharmaceuticals Market Drivers
Table 191. RNA-based Biopharmaceuticals Market Challenges
Table 192. RNA-based Biopharmaceuticals Market Restraints
Table 193. RNA-based Biopharmaceuticals Distributors List
Table 194. RNA-based Biopharmaceuticals Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA-based Biopharmaceuticals Product Picture
Figure 2. Global RNA-based Biopharmaceuticals Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global RNA-based Biopharmaceuticals Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global RNA-based Biopharmaceuticals Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Therapeutics
Figure 6. Global Therapeutics Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Vaccines
Figure 8. Global Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global RNA-based Biopharmaceuticals Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global RNA-based Biopharmaceuticals Sales Market Share by Type in 2022 & 2034
Figure 11. North America RNA-based Biopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 12. North America RNA-based Biopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 13. Europe RNA-based Biopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 14. Europe RNA-based Biopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 17. Latin America RNA-based Biopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 18. Latin America RNA-based Biopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by RNA-based Biopharmaceuticals Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by RNA-based Biopharmaceuticals Revenue in 2022
Figure 23. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Cancer
Figure 25. Global Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Diabetes
Figure 27. Global Diabetes Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Tuberculosis
Figure 29. Global Tuberculosis Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Cardiovascular Diseases
Figure 31. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global RNA-based Biopharmaceuticals Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2022 & 2034
Figure 36. North America RNA-based Biopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 37. North America RNA-based Biopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 38. Europe RNA-based Biopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 39. Europe RNA-based Biopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific RNA-based Biopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 42. Latin America RNA-based Biopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 43. Latin America RNA-based Biopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. RNA-based Biopharmaceuticals Manufacturing Cost Structure
Figure 47. RNA-based Biopharmaceuticals Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries